Dr. Mark Zafereo, MD

• Head & Neck Surgical Oncology

• Ear, Nose, and Throat

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Md Anderson Cancer Center Houston

  Fellowship Hospital, 2011

• Baylor College Of Medicine

  Residency Hospital, 2010

• Baylor University

  Residency Hospital, 2010

• University Of Texas Health Sciences Center At Houston Mcgovern Medical School

  Internship Hospital, 2006

• University Of Texas Health Sciences Center At Houston Mcgovern Medical School

  Medical School, 2005

• University Of Texas / Austin Campus

  Undergraduate School, 2001

• Association ofp53codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck, 2010-05-15

• Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response, 2014-11-28

• Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck, 2009-04-28

• Management of the Neck in Well-Differentiated Thyroid Cancer., 2020-11-14

• Quantitative Pretreatment Computerized Tomographic Volumetry is Associated with Oncologic Outcomes in Patients with T4a Squamous Carcinoma of the Larynx, 2017-05-02

• The synergy of germline C634Y and V292MRETmutations in a northern Chinese family with multiple endocrine neoplasia type 2A, 2020-09-29

• Functional polymorphisms in theinsulin-like binding protein-3gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans, 2012-03-13

• Genetic variants of thep53andp73genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck, 2011-06-29

• p14ARFGenetic Polymorphisms and Susceptibility to Second Primary Malignancy in Patients with Index Squamous Cell Carcinoma of the Head and Neck, 2010-11-08

• Facial nerve electrodiagnostics for patients with facial palsy: a clinical practice guideline, 2020-04-08

• Three-Dimensional Imaging Assessment of Anatomic Invasion and Volumetric Considerations for Chemo/Radiotherapy-Based Laryngeal Preservation in T3 larynx Cancer, 2018-02-10

• Neighborhood Deprivation and Clinical Outcomes among Head and Neck Cancer Patients, 2012-03-14

• Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers, 2012-06-19

• Matched Pair Analysis of Race or Ethnicity in Outcomes of Head and Neck Cancer Patients Receiving Similar Multidisciplinary Care, 2009-09-08

• Thyroid carcinoma metastasizing to the submandibular gland: Sonographic findings, 2020-02-11

• Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus, 2016-03-21

• p73G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck, 2009-12-01

• Incidence and Pattern of Second Primary Malignancies in Patients with Index Oropharyngeal Cancers versus Index Non-oropharyngeal Head and Neck Cancers, 2013-04-19

• TNF-apromoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx, 2014-02-27

• FASandFASLGgenetic variants and risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck, 2010-05-25

• The influence of timing, radiation and reconstruction on complications and speech outcomes with tracheoesophageal puncture, 2016-07-09

• American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment, 2022-03-11

• Complications, Hospital Length of Stay, and Readmission after Total Laryngectomy, 2016-12-27

• Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?, 2022-04-14

• Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib inBRAFV600E-Mutated Anaplastic Thyroid Carcinoma, 2019-08-19